Christopher Mutz Biography and Net Worth

Insider of ANI Pharmaceuticals

Mr. Mutz joined ANI in February 2021 and serves as the Company’s Head of its Rare Disease business. Prior to joining ANI, Mr. Mutz provided consulting services to pharma/biotech companies on pre-launch commercial strategy and life cycle management focused on rare diseases. Mr. Mutz has more than 25 years of experience in the pharmaceutical industry, including eight years at Alexion Pharmaceuticals and 10 years at Merck and Co. ("Merck"). From November 2011 to April 2019, Mr. Mutz held various leadership positions in sales and marketing business units at Alexion and served as Vice President, Metabolic Business Unit and then later Vice President, Neurology Business Unit. While at Merck, Mr. Mutz held various roles in U.S. Sales, U.S. Marketing and Global Marketing, including a leadership position in Merck’s China subsidiary. Mr. Mutz holds a B.A. in Biology from the University of Virginia and an M.B.A. from Cornell University.

What is Christopher Mutz's net worth?: The estimated net worth of Christopher Mutz is at least $6.43 million as of May 14th, 2025. Mr. Mutz owns 107,317 shares of ANI Pharmaceuticals stock worth more than $6,425,069 as of May 19th. This net worth estimate does not reflect any other investments that Mr. Mutz may own. Additionally, Mr. Mutz receives an annual salary of $867,920.00 as Insider at ANI Pharmaceuticals. Learn More about Christopher Mutz's net worth.
How old is Christopher Mutz?: Mr. Mutz is currently 52 years old. There are 8 older executives and no younger executives at ANI Pharmaceuticals. The oldest executive at ANI Pharmaceuticals is Mr. James G. Marken, Senior Vice President of Operations, who is 61 years old. Learn More on Christopher Mutz's age.
What is Christopher Mutz's salary?: As the Insider of ANI Pharmaceuticals, Inc., Mr. Mutz earns $867,920.00 per year. There are 3 executives that earn more than Mr. Mutz. The highest earning executive at ANI Pharmaceuticals is Mr. Nikhil Lalwani, President, CEO & Director, who commands a salary of $2,320,000.00 per year. Learn More on Christopher Mutz's salary.
How do I contact Christopher Mutz?: The corporate mailing address for Mr. Mutz and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at [email protected]. Learn More on Christopher Mutz's contact information.
Has Christopher Mutz been buying or selling shares of ANI Pharmaceuticals?: During the past quarter, Christopher Mutz has sold $241,800.00 in ANI Pharmaceuticals stock. Most recently, Christopher Mutz sold 4,000 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were sold at an average price of $60.45, for a transaction totalling $241,800.00. Following the completion of the sale, the insider now directly owns 107,317 shares of the company's stock, valued at $6,487,312.65. Learn More on Christopher Mutz's trading history.
Who are ANI Pharmaceuticals' active insiders?: ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Stephen Carey (Senior Vice President, Finance and Chief Financial Officer), Meredith Cook (Senior Vice President, General Counsel and Corporate Secretary), Krista Davis (Senior Vice President and Chief Human Resources Officer), Chad Gassert (Senior Vice President, Corporate Development and Strategy), Ori Gutwerg (Senior Vice President, Generics), Thomas Haughey (Director), Nikhil Lalwani (Pres), Nikhil Lalwani (President and Chief Executive Officer), James Marken (Senior Vice President, Operations and Product Development), Christopher Mutz (Insider), Antonio Pera (Director), Muthusamy Shanmugam (Head of R&D and COO of NJ Operations), Muthusamy Shanmugam (Head of R&D and COO), Renee Tannenbaum (Director), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.
Are insiders buying or selling shares of ANI Pharmaceuticals?: During the last year, insiders at the specialty pharmaceutical company sold shares 25 times. They sold a total of 159,809 shares worth more than $9,777,989.53. The most recent insider tranaction occured on May, 15th when SVP Ori Gutwerg sold 881 shares worth more than $52,921.67. Insiders at ANI Pharmaceuticals own 11.1% of the company. Learn More about insider trades at ANI Pharmaceuticals.
Information on this page was last updated on 5/15/2025.

Christopher Mutz Insider Trading History at ANI Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/14/2025	Sell	4,000	$60.45	$241,800.00	107,317
5/21/2024	Sell	2,000	$61.61	$123,220.00	83,277

Christopher Mutz Buying and Selling Activity at ANI Pharmaceuticals

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Today's Range

Now: $60.16

$58.94

$60.20

50 Day Range

MA: $66.91

$59.53

$72.95

2 Week Range

Now: $60.16

$52.50

$77.00

Volume

268,194 shs

Average Volume

298,783 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.56

Christopher Mutz Biography and Net Worth

What is Christopher Mutz's net worth?

How old is Christopher Mutz?

What is Christopher Mutz's salary?

How do I contact Christopher Mutz?

Has Christopher Mutz been buying or selling shares of ANI Pharmaceuticals?

Who are ANI Pharmaceuticals' active insiders?

Are insiders buying or selling shares of ANI Pharmaceuticals?